| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
Epstein-Barr virus induced 3 | 0.474 | 0.808 | 0.11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
mitochondrial ribosomal protein L28 | 0.505 | 0.731 | 2.0E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | |||||||||
|
proprotein convertase subtilisin/kexin type 9 | 0.482 | 0.808 | 2.7E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
submaxillary gland androgen regulated protein 3B | 0.601 | 0.654 | 0.39 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
fatty acid binding protein 1 | 0.588 | 0.692 | 9.8E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
EPH receptor A4 | 0.566 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
H3 histone pseudogene 9 | 0.505 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | |||||||||
|
SUB1 regulator of transcription | 0.465 | 0.846 | 0.89 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
growth factor independent 1 transcriptional repressor | 0.546 | 0.769 | 0.25 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
protein tyrosine phosphatase 4A3 | 0.566 | 0.654 | 4.5E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
nuclear transport factor 2 like export factor 1 | 0.505 | 0.731 | 0.65 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
galectin 1 | 0.435 | 0.846 | 4.5E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2016 | ||||||||
|
TNF superfamily member 11 | 0.453 | 0.846 | 4.9E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | ||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1988 | 2014 | |||||||||
|
envoplakin | 0.599 | 0.423 | 5.7E-25 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2009 |